These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18797424)

  • 1. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer.
    Davila JA; Chiao EY; Hasche JC; Petersen NJ; McGlynn KA; Shaib YH
    Pancreas; 2009 Jan; 38(1):e18-25. PubMed ID: 18797424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
    Amin S; Lucas AL; Frucht H
    Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study.
    Han D; Gao F; Liu JL; Wang H; Fu Q; Yang GW
    BMC Cancer; 2021 May; 21(1):560. PubMed ID: 34001035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals.
    Dhar VK; Hoehn RS; Kim Y; Xia BT; Jung AD; Hanseman DJ; Ahmad SA; Shah SA
    J Gastrointest Surg; 2018 Jan; 22(1):98-106. PubMed ID: 28849353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.
    Enewold L; Harlan LC; Tucker T; McKenzie S
    J Gastrointest Cancer; 2015 Mar; 46(1):9-20. PubMed ID: 25403828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
    Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
    J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.
    Parmar AD; Vargas GM; Tamirisa NP; Sheffield KM; Riall TS
    Surgery; 2014 Aug; 156(2):280-9. PubMed ID: 24851723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
    Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
    Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
    J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in treatment and survival of male breast cancer.
    Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
    J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
    He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
    Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database.
    Alhatem A; Quinn PL; Xia W; Chokshi RJ
    J Surg Res; 2021 Mar; 259():62-70. PubMed ID: 33279845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged?
    Bertens KA; Massman JD; Helton S; Garbus S; Mandelson MM; Lin B; Picozzi VJ; Biehl T; Alseidi AA; Rocha FG
    J Surg Oncol; 2018 Jun; 117(8):1655-1663. PubMed ID: 29761510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
    Chen X; Liu G; Wang K; Chen G; Sun J
    Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.
    Lund JL; Stürmer T; Sanoff HK; Brookhart A; Sandler RS; Warren JL
    Cancer; 2013 Jun; 119(11):2038-47. PubMed ID: 23512326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.